{
  "abstract_id": "1356",
  "abstract_title": "Use of lucicebtide (ST101) in glioblastoma patients by antagonism of C/EBP?-dependent mesenchymal cell transition and immunosuppressive M2 macrophage polarization.",
  "pipeline_status": "success",
  "last_completed_step": "step5_consolidation",
  "failed_step": null,
  "error": null,
  "steps": {
    "step1_regimen": {
      "status": "success",
      "llm_calls": 1
    },
    "step2_extraction": {
      "status": "success",
      "llm_calls": 1
    },
    "step3_selection": {
      "status": "success",
      "llm_calls": 1
    },
    "step4_explicit": {
      "status": "success",
      "llm_calls": 1
    },
    "step5_consolidation": {
      "status": "success",
      "llm_calls": 0
    }
  },
  "total_llm_calls": 11,
  "last_updated": "2026-01-16T14:54:48.525764Z"
}